Skip to main content
Caplight Logo









Renexxion, Inc.

Renexxion, Inc.

Private
Los Altos, CaliforniaHealthcare & Life Scienceshttps://www.renexxion.com/

Last Round

Reverse Merger

Mar 6, 2025

Company Overview

Renexxion, Inc. is a biotechnology company that develops pharmaceutical therapies for patients with gastrointestinal disorders.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

biopharmaceuticalgastrointestinal disordersprokinetic drugnaronapridegastroenterologyclinical-stage biotechgastroparesis treatmentdrug developmentsmall-molecule drugfunctional dyspepsiaGERDgastroesophageal reflux diseasepharma licensingGI motilitybiotech pipeline

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Renexxion, Inc. Comparables

Compare Renexxion, Inc. with similar companies based on industry and business-model similarity.

Renexxion, Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Processa Pharmaceuticals
85%
Retromer Therapeutics
83%
Aclipse Therapeutics
82%

Renexxion, Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Reverse MergerMar 6, 2025
Private PlacementApr 12, 2022
AngelSep 1, 2014

Renexxion, Inc. Investors

Notable investors and investment history

Renexxion, Inc. investors
InvestorRounds
Atheneos VenturesAngel

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 6, 2025

    Completed a reverse merger funding round.

  • Apr 12, 2022

    Raised a Private Placement round with investment from gemny.

Renexxion, Inc. Filings

Explore SEC and related filing metadata, where available.

Renexxion, Inc. filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Renexxion, Inc.'s valuation, stock price, and market status.

Is Renexxion, Inc. a public or private company?

Renexxion, Inc. is a private company.

What is the current stock price of Renexxion, Inc.?

Renexxion, Inc. is a private company with no public stock price. No recent secondary market data is available.

How much is Renexxion, Inc. worth (valuation)?

Valuation information for Renexxion, Inc. is not publicly available.

Can I buy Renexxion, Inc. stock?

Renexxion, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Renexxion, Inc.'s last funding round?

Renexxion, Inc.'s most recent funding round was Reverse Merger on March 6, 2025.

Who are the main investors in Renexxion, Inc.?

Key investors in Renexxion, Inc. include Atheneos Ventures.

Will Renexxion, Inc. IPO soon?

No public IPO plans have been announced for Renexxion, Inc..

How can I track Renexxion, Inc. secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Renexxion, Inc.'s secondary market activity and sign up for updates.

Firmographic Details

HeadquartersLos Altos, California
Year Founded2014
Last FundingMar 6, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?